Home|Contact|Imprint|Search
  
News| Events| Companies & Institutes| The Network| eLetter / Newsletter
Network News
Life Science News
Archive

Search  

News - Archive

23.12.2009  netzwerk nordbayern is looking for innovative founders
22.12.2009  4SC Announces Clinical Advancements in its Oncology Pipeline
21.12.2009  Growth financing: LipoFIT receives capital for new diagnostics
14.12.2009  New applications in living cells - Nanobodies modify protein shape and function
10.12.2009  4SC AG Receives Research Grant from the Bavarian Research Foundation
01.12.2009  European Patent Granted for the Small-Molecule 4SC-101
01.12.2009  Hepa Wash closes €3.8m Series-A financing round
01.12.2009  Agennix AG Announces Positive Results with Talactoferrin in Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial in Severe Sepsis
01.12.2009  Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet
29.11.2009  WILEX AG receives preliminary results of the phase III trial with the diagnostic REDECTANE®
25.11.2009  Corimmun Has Successfully Started a Phase I Clinical Trial with its lead compound COR-1
24.11.2009  Roche and the Department of Health of Junta de Andalucía Collaborate in Spanish Medical Genome Project
24.11.2009  Dr. Simon Moroney Awarded Bavarian State Medal for Outstanding Services to the Bavarian Economy
24.11.2009  Micromet Enters Into Agreement With Lonza for the Manufacture of Blinatumomab
23.11.2009  Bio-Gate AG enters into development and licensing agreement with internationally leading medical engineering company
20.11.2009  KINAXO Completes Financing Round to Enhance Biomarker Development
19.11.2009  World’s Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol
09.11.2009  MorphoSys Receives Regulatory Approval to Start Phase 1b/2a Clinical Trial for MOR103 Program
09.11.2009  4SC Announces First Patient Treated in Phase IIb Rheumatoid Arthritis Study with 4SC-101
06.11.2009  High-throughput DNA-isolation robot HEDIS ticks again for research
30.10.2009  b3c newswire offers access to Web 2.0 PR technologies to optimize news visibility
30.10.2009  Top research versus market obstacles for innovative products
29.10.2009  Review: Cooperation Forum 'Functional Plant-derived Ingredients'
29.10.2009  Micromet and Sanofi-aventis Sign Global Collaboration and License Agreement for New Solid Tumor BiTE Antibody
27.10.2009  Drug Development 2009: Strategies – Technologies – Therapies
21.10.2009  KINAXO Starts Collaboration with Roche in the Field of Phosphoproteomics
20.10.2009  MorphoSys and Daiichi Sankyo Forge Alliance to Develop Novel Antibody Therapies against Hospital-Acquired Infections
15.10.2009  KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification
09.10.2009  Pieris reports preclinical development progress of its next generation VEGF antagonist
09.10.2009  MediGene successfully completes patient recruitment into EndoTAG(TM)-1 Phase II breast cancer trial
07.10.2009  IDEA updates on Diractin® (ketoprofen in Transfersome® gel) status
05.10.2009  MediGene Receives Further European Patent on EndoTAG(TM)-1
02.10.2009  WILEX receives approval for Phase I trial with MEK inhibitor WX-554
29.09.2009  Preliminary data of MESUPRON® show impressive increase in overall survival of patients with pancreatic cancer
29.09.2009  MediGene Signs Agreement with Solvay for the Commercialization of Veregen® in Germany, Austria, and Switzerland
24.09.2009  New Network Optical Technologies in Photodynamics
24.09.2009  New Research Projects in Immunotherapy at BayImmuNet
23.09.2009  Sloning closes growth financing round led by LBBW-Venture
15.09.2009  Foundation stone laid for 3rd construction in Regensburg
15.09.2009  Pieris AG enters into Anticalin Collaboration with Allergan, Inc.
14.09.2009  FDA and EMEA grant orphan drug designation for Antisense Pharma's investigational drug trabedersen in pancreatic carcinoma
14.09.2009  AbD Serotec and FIND Sign Agreement to Develop Temperature Stable Antibodies for In Vitro Diagnostics
09.09.2009  MediGene AG Receives Marketing Authorization for Veregen® in Germany
08.09.2009  MorphoSys Announces Clinical Milestone in Cancer Program with Bayer Schering Pharma
07.09.2009  SuppreMol receives public research funding for its lead project SM101
01.09.2009  Bicoll and Genfit announce the identification of active compounds for inflammatory diseases
01.09.2009  Patient recruitment in Phase III registration trial with REDECTANE® successfully completed
18.08.2009  4SC commences phase II trial in Hepatocellular Carcinoma (HCC) with the HDAC inhibitor 4SC-201
18.08.2009  Scientist at the Technische Universität München illuminate pathways of proteasome blocking
10.08.2009  immatics obtains further important EP patents covering its lead product IMA901 and US patent for MUC-1 peptide
06.08.2009  From exploring plant ingredients with health benefits to launching new products
04.08.2009  b3c newswire offers custom options for PR-distribution of event-related news
29.07.2009  Sloning BioTechnology and Henkel to Co-Operate in Enzyme Development
28.07.2009  Plant-derived Ingredients for novel functions and added value in food, pharma and cosmetics
10.07.2009  MediGene receives Positive Assessment on Market Authorisation for Veregen® in First European Countries
09.07.2009  AbD Serotec and Spinreact Sign Supply Agreement for Antibodies Used in Clinical Diagnostic Kits
08.07.2009  Affectis Pharmaceuticals AG Receives Research Grant from the State of Bavaria Technology Program
07.07.2009  Actelion Chooses GENEART as Exclusive Supplier for DNA Engineering & Processing Services
07.07.2009  AVONTEC broadens US patent protection for its lead candidate
06.07.2009  MorphoSys Secures Full-Term of Strategic Alliance
06.07.2009  BioPark Regensburg celebrates 10 year Company Jubilee
06.07.2009  High-Tech Gründerfonds, Bayern Kapital and BioM AG to invest in Intana Bioscience GmbH
01.07.2009  Professor Axel Ullrich honored with Dr. Paul Janssen Award
29.06.2009  MorphoSys Announces Clinical Milestone in Therapeutic Antibody Program
25.06.2009  Bayerns Wirtschaftsminister Zeil ernennt Beirat Biotechnologie
24.06.2009  MorphoSys Reports Filing for Phase 1b/2a Trial for its Lead Program MOR103 in Rheumatoid Arthritis
24.06.2009  GENEART Supports iGEM Contest for the Third Year in a Row
24.06.2009  Zwei bayerische Anträge in der Endauswahl des 2. Spitzenclusterwettbewerbs des BMBF
23.06.2009  Nanion and Axiogenesis present parallel patch clamp recordings of action potentials from Cor.At® Cardiomyocytes
23.06.2009  GPC Biotech Shareholders Approve Merger Into New Agennix AG
23.06.2009  MediGene Concludes Agreement with Juste for the Commercialization of Veregen® in Spain and Portugal
19.06.2009  GENEART Supports the UK HIV Vaccine Consortium (UK HVC) in Developing a DNA Vaccine Candidate against HIV
18.06.2009  Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203
16.06.2009  Kabinett gibt Startschuss für neuen Wagniskapitalfonds
16.06.2009  MorphoSys Announces Extension of Antibody Alliance with Schering-Plough
10.06.2009  Bio-Gate Subsidiary BioEpiderm opens up European Cosmetics Markets for its Cosmetics Business
10.06.2009  Mexican Ministry of Agriculture and National Institute for Epidemiology buy Advalytix AmpliSpeed and Implen Nanophotometer to screen for H1N1 (Swine Flu) and agricultural pathogens
04.06.2009  GENEART Receives Major Contract from MPI for Molecular Genetics within the BMBF Joined Project “IG Mutanom”
03.06.2009  Nanion again nominated for prestigious award
20.05.2009  FDA Grants Orphan Drug Designation for MediGene's Drug Candidate EndoTAG(TM)-1
18.05.2009  Daiichi Sankyo and MorphoSys Expand Collaboration with two new Cancer-Related Antibody Programs
18.05.2009  AbD Serotec and BBInternational Announce Cooperation and Co-Marketing Agreement
15.05.2009  Max Planck Innovation and LSP to launch DDC Ventures, a new pharmaceutical Venture Capital Fund
11.05.2009  4SC AG receives research funding from the Federal Ministry of Education and Research under the “Medical systems biology – MedSys” scheme
08.05.2009  "Businessplan Wettbewerb Nordbayern 2009": Best Founders awarded
08.05.2009  Bavarian biotechnology sector defies the financial and economic crisis
07.05.2009  Süd-Chemie and Linde launch production of climate-friendly biofuels
05.05.2009  MorphoSys Achieves Clinical Milestone and Payment in Antibody Alliance
04.05.2009  Network Life Science at the BIO 2009 in Atlanta
04.05.2009  GENEART Synthesizes Genes for Swine Flu Vaccine in Record Speed
29.04.2009  MediGene AG appoints Dr. Frank Mathias as new Chief Executive Officer
29.04.2009  b3c has launched a new specialized channel on "Biomanufacturing"
27.04.2009  Antisense Pharma begins pivotal Phase III clinical trial with trabedersen in aggressive brain tumors
27.04.2009  Current Study: Munich Biotech and Pharma Site Sends out Positive Signals
23.04.2009  EU Approval for Removab®: First Trifunctional Antibody Hits Market
21.04.2009  Bio-Gate starts strategic readjustment
08.04.2009  Innovation Award 2009 of the German BioRegions
03.04.2009  "Forum Life Science 2009" Congress-TV now available
23.03.2009  "Forum Life Science 2009": Concepts and strategies for sustainable solutions in pharma, nutrition and chemistry presented at the international congress
20.03.2009  Now Hyglos - Profos AG has been acquired by private investors
13.03.2009  MorphoSys Strengthens Patent Position on its Core HuCAL Technology in Europe
12.03.2009  Genomatix gets Patent for Comparative Genomics Method
12.03.2009  Roche and Genentech reach a friendly agreement to combine the two organizations and create a leader in healthcare innovation
04.03.2009  4SC AG initiates Phase IIa Clinical Trials of 4SC-101 in Crohn’s Disease
24.02.2009  Kinaxo contributes its quantitative phosphoproteomics platform to a drug efficiency study
20.02.2009  Ascenion Receives Equity in Oncology Start-up MBiotec
19.02.2009  Positive CHMP Opinion for Removab® Validates TRION’s Triomab® Technology
18.02.2009  GPC Biotech and Agennix Announce Proposed Merger
17.02.2009  Nanion opens US-office in New Jersey
10.02.2009  Understanding the interaction of nutrition and health – towards preventive health strategies
10.02.2009  'omics' technologies for high-performance biotech production
10.02.2009  Olympic run to fill drug pipelines
10.02.2009  Developing Innovative Food Products
10.02.2009  Shaping the future with a biobased industry
10.02.2009  The pharmaceutical challenges for an ageing population
05.02.2009  US Patent Office grants a new patent to IDEA AG
05.02.2009  MediGene to be Listed on TecDAX Index
05.02.2009  GENEART receives European Patent for Screening Process for Antiviral Therapeutics
04.02.2009  GeneCore Facility at the EMBL Purchases Genomatix' Next Generation Sequencing Data Analysis Systems
03.02.2009  ibidi establishes partnership with Seahorse Bioscience
03.02.2009  Pieris reports development progress for Anticalin® PRS-050, a next generation VEGF antagonist
29.01.2009  GVK Biosciences and Crelux set up Fragment-based Drug Discovery Platform to deliver Lead Molecules
28.01.2009  Genomatix Joins Illumina-Connect Program
22.01.2009  Brokerage Event 'MedTech - Pharma - Biotech
22.01.2009  Forum Life Science 2009
21.01.2009  Roche invests in Diagnostics Operations Complex Building in Penzberg
21.01.2009  Nanion nominated for The German Industry’s Innovation Award
20.01.2009  GENEART Receives European Patent for Selective Evolution of Proteins
19.01.2009  MorphoSys Provides Update on Pipeline Activities in 2009
15.01.2009  Bio-Gate AG wins another Development Contract
12.01.2009  Micromet Enters Into Agreement for BiTE Antibody with Bayer Schering Pharma AG
09.01.2009  UCB and WILEX to enter into strategic alliance to develop UCB's preclinical oncology portfolio
19.12.2008  IDEA AG completes recruitment in two clinical studies with Diractin®
16.12.2008  GENEART and MorphoSys Successfully Cooperate in HuCAL PLATINUM® Project
11.12.2008  MorphoSys Announces Second Clinical Milestone in Therapeutic Antibody Program
09.12.2008  Enrollment Opened in Phase 1 Trial Evaluating RGB-286638 in Patients with Advanced Solid Tumors
09.12.2008  Dose finding in Phase-I trial for 4SC-201 successfully concluded
09.12.2008  MorphoSys Unveils New Antibody Library, HuCAL PLATINUM®
04.12.2008  MorphoSys Recognized as Technology Pioneer 2009 by the World Economic Forum
01.12.2008  Important success for the development of novel potentials in the medical engineering market
27.11.2008  European Patent Office decides to grant new European Patent for Veregen®
26.11.2008  GENEART receives major contract from the Wellcome Trust Sanger Institute
26.11.2008  MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
25.11.2008  Key US Patent Granted on Antibodies Against GM-CSF to Treat Inflammatory Disorders
18.11.2008  MorphoSys and Wacker Intensify Cooperation to Use Wacker Technology for Production of Antibodies
18.11.2008  Nanion presents new HTS patch clamp
13.11.2008  MOR103 Shows Ability to Inhibit Disease in an Established RA Model
10.11.2008  GENEART Successfully Concludes Project to Complete the NIH’s “Mammalian Gene Collection“
09.11.2008  Fragment Based Screening Service at CRELUX and ZoBio
06.11.2008  Neue Ausbildungsbroschüre des netzwerk|nordbayern für Oktober 2008 bis März 2009 erschienen
05.11.2008  IDEA AG reports data of a 12-month comparative study of Diractin® versus naproxen
23.10.2008  GENEART again among Germany‘s Top “Technology Fast 50” Companies
23.10.2008  Origenis Broadens Research Alliance with Alcon
23.10.2008  From renewable raw materials towards biobased applications
23.10.2008  Perspectives of industrial biopolymers – from an academic and industrial view
23.10.2008  Biopolymers – applications in automotive, textile and medicine
23.10.2008  Biosynthesis of polymers
22.10.2008  Tour of the Competence Centre for Renewable Resources in Straubing
21.10.2008  4SC reports on positive results from a clinical phase I trial with cancer drug candidate 4SC-201
20.10.2008  MediGene Reports Positive Final Results from EndoTAG(TM)-1 Phase II Study in Pancreatic Cancer
20.10.2008  Lighthouses for the Integrated Biorefinery Concept for Bio-based Products in EU Member States
13.10.2008  Kinaxo enters into an agreement with Boehringer Ingelheim
10.10.2008  The Upper Palatinate is a rapidly expanding location for biotechnology firms
09.10.2008  GENEART Reaches Contest Final 'Entrepreneur of the Year 2008'
07.10.2008  Geneart wins 'European Biotechnica Award'
01.10.2008  MediGene Spins Out mTCR Programme
01.10.2008  Roche invests about € 136 million for a diagnostics building in Penzberg
29.09.2008  Shionogi Extends Research Partnership with MorphoSys
25.09.2008  AVONTEC receives research grant from the Federal Ministry of Education and Research (BMBF)
24.09.2008  Roche Diagnostics celebrates installation of the 5000th MODULAR ANALYTICS system
23.09.2008  e2v to Establish Next Generation Biosensor System Using AbD Serotec-generated HuCAL Antibodies
18.09.2008  LMU opens Biology Centre at the HighTechCampus
17.09.2008  GENEART Supports Advancements in Synthetic Biology as Partner of the iGEM Competition
16.09.2008  MediGene reports positive 12-month survival data for EndoTAG(TM)-1 from Phase II pancreatic cancer study
08.09.2008  GENEART founds a subsidiary on the west coast of the US
02.09.2008  MorphoSys announces publication of first MOR103 data
28.08.2008  TOP 100 der innovativsten Unternehmen im Mittelstand
25.08.2008  Bio-Gate strengthens its position on the US medical technology market
25.08.2008  GENEART has been elected Finalist of the “European Biotechnica Award 2008”
19.08.2008  MediGene: European Patent Granted on the Application of Anti-L1 Antibodies in Cancer Therapy
12.08.2008  WILEX starts patient recruitment in Phase II breast cancer trial
05.08.2008  Minister Emilia Müller visits Bionorica
05.08.2008  Topping-out ceremony for Biocubator in Straubing
31.07.2008  Bavaria is one of the top biotech locations
31.07.2008  MediGene sells licensee rights to the drug Oracea® to Galderma
24.07.2008  Kinaxo Biotechnologies Awarded Grant to Expand Applications for its Chemical Proteomics Platform
24.07.2008  CFM Oskar Troptzsch is celebrating its 220 birthday!
23.07.2008  MorphoSys Licenses RapMAT Technology to Astellas
22.07.2008  Cenix BioScience Signs Research Agreement with Regulus Therapeutics for miRNA-Targeted Drug Discovery
18.07.2008  Wacker validates scalability of Anticalin® production with E.coli
18.07.2008  First AbD Serotec generated HuCAL Antibodies Distributed as Part of Clinical Diagnostic Kits for Autoimmune Diseases by Phadia
18.07.2008  MediGene exercises option for Anti-L1 Monoclonal Antibody and continues collaboration with DKFZ
15.07.2008  MorphoSys and Integrated BioTherapeutics Provide Update Regarding USAMRIID Biodefense Project
15.07.2008  Bavarian network for clinical studies founded
11.07.2008  Boehringer Ingelheim Gains Access to Additional MorphoSys Technology
11.07.2008  GENEART Receives a Grant for the Targeted Design of Vaccine Candidates
08.07.2008  Step Award 2008
01.07.2008  US National Cancer Institute Expands Contract with GENEART
26.06.2008  BIO Europe 2010 takes place in Munich
24.06.2008  GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin
24.06.2008  MediGene Achieves Positive Results with RhuDex® in Clinical Phase IIa Trial
24.06.2008  Boehringer Ingelheim and GENEART collaborate
19.06.2008  Bavaria shows flag at the BIO 2008
17.06.2008  OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
16.06.2008  Delegation's journey to Canada
12.06.2008  GPC Biotech Announces Granting of European Patent Related to Satraplatin
10.06.2008  Bavaria as a leading site for Biotechnology in Europe
10.06.2008  Bio-Gate AG: antimicrobial silver particles on the rise
09.06.2008  The Life Science team of Bayern Innovativ at the BIO 2008 in San Diego (Booth 623, German Pavilion)
06.06.2008  WILEX and IBA enter into worldwide marketing, distribution and sales agreement on REDECTANE®
05.06.2008  4SC to acquire Nycomed oncology projects
03.06.2008  Bavarian Nordic enters clinical trials with prostate cancer vaccine
02.06.2008  MediGene focuses its strategy on oncology and immunology
29.05.2008  4SC and ViroLogik conclude a licensing and cooperation agreement
28.05.2008  GPC Biotech announces data from several Satraplatin clinical trials to be presented at ASCO annual meeting
21.05.2008  DAIICHI SANKYO takes over U3 Pharma AG
19.05.2008  Schering-Plough extends antibody alliance with MorphoSys
19.05.2008  Patient recruitment started in Phase III registration trial with CA9-SCAN
15.05.2008  GENEART and QIAGEN announce marketing partnership for mammalian genes
15.05.2008  Germany's Minister of Finance Peer Steinbrück visited the IZB
15.05.2008  Wacker Biotech successfully completed feasibility study to evaluate its proprietary secretion technology
13.05.2008  KINAXO Biotechnologies enters agreement with Onconova Therapeutics Inc.
08.05.2008  Exportpreis Bayern 2008
07.05.2008  CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
06.05.2008  Süd-Chemie and Linde to jointly develop production plants for second-generation biofuels
05.05.2008  Clusterfonds 'Start Up!' enters the market
30.04.2008  Biopharmaceuticals – New technologies enable therapeutic progress
28.04.2008  MorphoSys announces completion of first dosing in phase 1 trial for MOR103 program
25.04.2008  European Regulatory Authority (EMEA) recommends granting of marketing authorization for MediGene's drug Oracea®
24.04.2008  The US National Cancer Institute extends its contract with GENEART
24.04.2008  MorphoSys and the Leibniz-Institut für Molekulare Pharmakologie sign broad research partnership
24.04.2008  Sloning and the Kornberg group at Stanford University starting evaluation project regarding the synthesis of a Statistically Randomized Gene Library
23.04.2008  Micromet enrolls first patient in a phase 1 clinical trial with MT110, the first BiTE antibody for treatment of solid tumors
21.04.2008  KINAXO Biotechnologies enters agreement with Takeda
14.04.2008  "Hochschul-Gründer-Preis": Xenopharm and Raman BioMed awarded
14.04.2008  Presentation of Report 2007 'Biotechnology in Bavaria'
10.04.2008  Bayern Innovativ Joint Pavilion at Analytica 2008: Exhibitors draw a positive balance
07.04.2008  German patent protects novel screening method for antiviral therapeutics based on synthetic genes
01.04.2008  Professor Sickmann from the University Würzburg among the winners of the Analytica Research Prize 2008
31.03.2008  Cutsomer Test for the detection of Legionella bacteria
27.03.2008  Pieris raises EUR 25 M (US$ 38 M) in Series B financing round
26.03.2008  DAIICHI SANKYO extends alliance with MorphoSys for use of HuCAL GOLD to develop novel antibody therapies
19.03.2008  Information and services from one source
17.03.2008  MorphoSys obtains agreement for production of antibody material in MOR202 program with Crucell and DSM
17.03.2008  MediGene achieves excellent efficacy data of EndoTAG(TM)-1 in clinical phase II trial in pancreatic carcinoma
17.03.2008  GENEART is awarded a grant to advance its GeneOptimizer® technology as part of a collaborative EU project
11.03.2008  Proteros Biostructures expands successful protein crystallography collaboration with Osi Pharmaceuticals
05.03.2008  AbD Serotec receives large research antibody order from proteomics specialist Proteomika
29.02.2008  Carl-Duisberg award for achievements in white biotechnology
29.02.2008  Two Bavarian companies in final round of BioPharma initiative
28.02.2008  Network ‚Life Science Bavaria’ at the BIO 2008 in San Diego
27.02.2008  Best ten business concepts of Northern Bavaria awarded
26.02.2008  Bavarian companies present at the Forum 'Innovations & Technologies' during Analytica 2008
22.02.2008  Project group of the Fraunhofer Institute of Toxicology and Experimental Medicine (ITEM) starts in the BioPark Regensburg
26.09.2007  Using nature's toolbox for industrial processes
25.07.2007  FDA Oncologic Drugs Advisory Committee recommends that FDA wait for overall survival results from Satraplatin phase III trial
16.07.2007  KINAXO receives EUR 1 Mio funding to quantify drug interactions with cellular protein targets
13.07.2007  East Bavaria is becoming a center for bioenergy
12.07.2007  Entelechon, Spetrix and LipoFit amongst finalists of 'Businessplan Wettbewerb Nordbayern 2007'
09.07.2007  Roche and Alnylam form major alliance on RNAi therapeutics
07.07.2007  Cancer-fighting virus shows promise in early clinical trial
04.07.2007  Olympus opens life science research centre in Munich
25.06.2007  Probiodrug AG acquires Ingenium Pharmaceuticals AG to form an integrated biopharmaceutical company
24.05.2007  Eurofins Medigenomix/ MWG Biotech sequence Wacker Chemie AG's bacterial protein production strain
23.05.2007  GENEART sponsors MIT’s 2007 International Genetically Engineered Machine Competition (iGEM)
22.05.2007  Scil Technology GmbH obtained competent authority approval for phase II periodontitis study
21.05.2007  Additional efficacy data from Satraplatin SPARC phase 3 investigational trial presented at annual meeting of American Urological Association
21.05.2007  Affectis Pharmaceuticals AG further strengthens management team
21.05.2007  Capital increase and placement of new 4SC AG shares
21.05.2007  Network ‚Life Science Bavaria’ at the BIO 2007 in Boston
16.05.2007  MorphoSys shareholder assembly approves three-for-one stock split - Dr Walter Blättler appointed new supervisory board member
15.05.2007  EXTEDO launches pan-European software for drug approvals agencies
13.05.2007  November AG to receive contributions by IBL GmbH and PROGEN GmbH
10.05.2007  2007 ASCO Annual Meeting - Clinical results on study with AP 12009 in anaplastic astrocytoma selected for poster discussion
10.05.2007  2007 ASCO Annual Meeting - data on systemic application of the TGF-beta2-inhibitor AP 12009 to be presented
10.05.2007  CALPORTIN Pharmaceuticals is winner of the 'Hochschul-Gründerpreis' of the 'netzwerk|nordbayern'
09.05.2007  MWG Biotech AG announces expansion of their UK and Ireland sales team
08.05.2007  4SC AG provides proof of concept for drug candidate SC75741 in the treatment of influenza A-infected mice
08.05.2007  Chief Financial Officer Alexander Dexne leaves MediGene AG
07.05.2007  KINAXO expands technology platform and secures additional venture capital
03.05.2007  GPC Biotech consolidates drug discovery activities
03.05.2007  MorphoSys reports completion of equity issue
03.05.2007  MorphoSys’ AbD Serotec and Chimera Biotec Extend Cooperation and Co-Marketing Agreement
02.05.2007  4th Munich Biotech Forum - Bio-M presents their latest reports
30.04.2007  GENEART receives patent for directed evolution of proteins
27.04.2007  Emergent Biosolutions requested to provide Biothrax® (Anthrax vaccine) to US Departments for Health and for Defence
27.04.2007  Successful development of BioGents based in Regensburg
26.04.2007  4SC AG: 60 patients in phase IIa clinical trial
25.04.2007  MediGene completes patient recruitment for clinical phase II trial of EndoTAG®-1 for the treatment of pancreatic cancer
24.04.2007  Annual results 2006 of Bio-Gate AG
23.04.2007  Scientists of the Leibniz-Institut for Molecular Pharmacology (FMP) established new method to accelerate drug development
20.04.2007  Scientist of the University of Würzburg found antibodies which block formation of bloot clot in order to prevent stroke
18.04.2007  European regulatory authorities accept MediGene's marketing authorization application for Polyphenon E® Ointment for review
18.04.2007  Winner of phase 2 of the Business Plan Competition North Bavaria 2007
16.04.2007  FDA accepts GPC Biotech's Satraplatin NDA for filing and grants priority review status
13.04.2007  MediGene initiates clinical phase II Trial of EndoTAGTM-1 for the treatment of hormone receptor negative breast cancer
13.04.2007  WILEX publishes Q1 2007 figures - results in line with expectations
05.04.2007  JDRF to collaborate with MediGene to develop an antigen-specific immunotherapeutic for type I Diabetes
04.04.2007  4SC AG notification of loss pursuant to §92 (1) AktG (German Stock Corporation Act)
04.04.2007  Bio-Gate obtained another patent
04.04.2007  Roche to acquire BioVeris to expand its leading ECL immunochemistry business into new market segments
03.04.2007  NascaCell Technologies AG receives US patent to generate microbodies
03.04.2007  WILEX gives positive update of current pivotal Phase III trial of RENCAREX®
02.04.2007  Roche acquires THP to expand its therapeutic antibody research
02.04.2007  Symrise: Strategic partnership with BRAIN and AnalytiCon Discovery
30.03.2007  4SC AG reports on successful financial year 2006
30.03.2007  CENiMED GmbH and GenPharmTox BioTech AG combine technology portfolios to broaden and strengthen the international market presence
30.03.2007  Pieris demonstrates potent anti-tumor activity of a VEGF-specific Anticalin® in preclinical studies
30.03.2007  Roche takes over 454 Life Sciences and strengthens its position in gene sequencing
28.03.2007  Annual Result 2006 of MediGene AG
28.03.2007  MediGene AG submits marketing authorization application for Polyphenon® E Ointment in Europe
28.03.2007  MorphoSys and Astellas enter antibody partnership - Deal seals MorphoSys's third Japanese pharmaceutical alliance
28.03.2007  November AG announces change in executive board
26.03.2007  Epidauros successful with patents for molecular diagnostics
26.03.2007  MorphoSys announces change in supervisory board
26.03.2007  US-Pharma corporate Merck & Co invests with new EMEAC headquarters in Bavaria
22.03.2007  Additional Data from Satraplatin SPARC Phase 3 Trail
20.03.2007  Ascenion mediates cooperation between HZI and Bayer Schering Pharma AG in the field of anti-cancer agents
20.03.2007  MorphoSys's AbD Serotec expands antibody license agreement with medical research council
19.03.2007  Antisense Pharma on road to success with AP 12009
15.03.2007  BioRegio Regensburg - Stable Growth (Annual report 2006)
15.03.2007  Entelechon developed new method for early diagnosis of diseases
15.03.2007  GPC Biotech reports financial results for fiscal year 2006
13.03.2007  GSF Scientist awarded the 'Gottfried Wilhelm Leibniz'-Prize - The award emphasizes relevance of stem cell research
13.03.2007  NascaCell Technologies AG receives funding from EUROTRANS-BIO
05.03.2007  Affectis Pharmaceuticals AG announces extension of research collaboration with Mitsubishi Pharma
05.03.2007  Forum Life Science 2007
01.03.2007  BioPark Regensburg introduces 'Interdisciplinary Agency BIOTECH'
01.03.2007  International One-on-One Cooperation Event MedTech – Pharma – Biotech
01.03.2007  TRANSBIO Partnering Event and Workshop
01.03.2007  Forum Life Science 2007 - Presentations are available on Congress-TV
28.02.2007  MorphoSys AG reports financial results for fiscal year 2006
28.02.2007  WILEX reports a successful financial year 2006 – positive outlook for 2007
27.02.2007  Bio-Gate files another application for approval in USA: Use of microscalic silver in non-medical applications
26.02.2007  Nanion presents automated internal perfusion with the Port-a-Patch
23.02.2007  Satraplatin shown to significantly reduce risk of disease progression in advanced hormone-refractory prostate cancer patients
21.02.2007  GPC Biotech launches expanded access program for oncology drug candidate Satraplatin in the U.S.
21.02.2007  Roche announces site in Penzberg as Center of Excellence
19.02.2007  CANDOR Biosciences starts distribution in Switzerland
16.02.2007  GPC Biotech submits NDA for lead oncology drug candidate Satraplatin
16.02.2007  Jubilee year 2006 closed on the upbeat - one billion in new investments wanted
16.02.2007  MediGene obtains European patent on EndoTAG(TM)-1
15.02.2007  MediGene AG successfully closes a capital Increase against cash contribution
12.02.2007  AbD Serotec and Thermo Fisher Scientific Sign Technology Agreement
12.02.2007  Novel live-cell assay for simultaneous monitoring of expression and interaction of proteins
09.02.2007  Max Planck researchers incorporate odorant receptors into artificial membranes
06.02.2007  4SC granted US patent for drug candidate SC12267 for treatment of rheumatic arthritis
05.02.2007  Less carbohydrates for cancer patients
05.02.2007  Roche continues to strengthen Research and Development
01.02.2007  IZB Freising-Weihenstephan selected as 'Place of Ideas' within the initiative "Land of Ideas 2007"
30.01.2007  New paths in the battle against lethal infections
25.01.2007  BioIT Alliance - CLC bio joins Microsoft in the alliance
25.01.2007  MorphoSys expands Japanese alliance with GeneFrontier
24.01.2007  GPC Biotech Announces Share Capital Issuance of up to 1,564,587 Shares
24.01.2007  GPC Biotech raises Euro 33.6 million in private placement
23.01.2007  4SC nominates NFkB development candidate and presents new data
23.01.2007  Affectis Pharmaceuticals AG in-licenses clinical stage compound for the treatment of psychiatric disorders
23.01.2007  MediGene initiates a clinical phase IIa trial of RhuDex® in rheumatoid arthritis
22.01.2007  CORIMMUN receives seed funding from High-Tech Gründerfonds, Bayernkapital and BioM AG
22.01.2007  MorphoSys Inaugurates New Facilities in Oxford, UK
18.01.2007  New paths towards therapy of Alzheimer and Parkinson: Virtual Institute researches neurodegenerative diseases
16.01.2007  Philip-Morris-Prize for Professor at the Ludwig-Maximilians-University Munich
12.01.2007  'Familie-Hansen-Preis' of Bayer AG awarded to GSF Neuro Scientist
11.01.2007  BioPark Regensburg expanded and once more fully booked
09.01.2007  EPIDAUROS and Osmetech to establish a strategic partnership
02.01.2007  Bio-Gate expands potential of application for antimicrobial coatings
28.12.2006  27 genes make molecular diagnosis of heart failure possible
21.12.2006  MediGene: Positive Phase II interim results in clinical trial of EndoTAG-1 against pancreatic cancer
20.12.2006  Forum Life Science 2007 - The Countdown has started
20.12.2006  MediGene's Acquisition of a License on OraceaTM Gives the Signal for Sales Organization Buildup
20.12.2006  MorphoSys enlarges therapeutic antibody collaboration with Pfizer - expansion doubles potential deal volume for MorphoSys
19.12.2006  Crystallographic analysis of Anticalin® targeting CTLA-4 confirms the excellent suitability of Pieris’ lipocalin scaffold to develop superior biotherapeutics
19.12.2006  MediGene and sanofi pasteur agree to undertake a collaborative Research Agreement to develop high affinity monoclonal T cell receptors (mTCRs) for vaccine validation
18.12.2006  MediGene's Drug Eligard® launched in Italy
15.12.2006  WILEX receives approval for clinical Phase II trial with oral WX-671 in pancreatic cancer
13.12.2006  GPC Biotech Responds to Arbitration Claim by Spectrum Pharmaceuticals
13.12.2006  WILEX enters into manufacturing and distribution agreement with IBA Molecular for the upcoming pivotal registration trial with CA9-SCAN
12.12.2006  Schwarz Pharma transfers project rights to 4SC
11.12.2006  GPC Biotech Presents Preliminary Clinical Data on Anticancer Monoclonal Antibody 1D09C3 at ASH
11.12.2006  Micromet Announces Interim Phase 1 Data of MT103 at the 48th Annual Meeting of the American Society of Hematology (ASH)
11.12.2006  MorphoSys Presents New RapMAT(TM) Antibody Technology
11.12.2006  Oxymetazolin als Entzündungshemmer in Schnupfenmitteln: Wirkmechanismus aufgeklärt
07.12.2006  Bicoll Group and Ricerca Bioscience, LLC enter significant collaboration agreement
06.12.2006  GENEART gewinnt „STEP-Award“ für Wachstumsunternehmen
06.12.2006  Micromet, Inc. and Serono Amend Collaboration Agreement and Continue Development of Adecatumumab (MT201)
04.12.2006  4SC AG has received clinical trial approval by authorities and has started the clinical phase IIa study
04.12.2006  Micromet, Inc. receives $ 10 million milestone payment from Serono for completion of Phase 2 clinical trials
01.12.2006  Six-Month Dosage of MediGene's Cancer Drug Eligard® Obtains Approval for Germany
30.11.2006  Aktuelle Ausgabe Bayern Innovativ TV
30.11.2006  Sales & Marketing agreement with InPheno
28.11.2006  MorphoSys and the Burnham Institute Sign Broad Research Partnership
27.11.2006  Avontec's lead product AVT-01 advances into multiple-dosing Phase 2a studies in asthma.
27.11.2006  Development of an innovative HIV vaccine at the University Regensburg
27.11.2006  EPOBIO - Plant Potential in the Pipeline
23.11.2006  Pumacy und trimedes LifeScience gründen Joint Venture
23.11.2006  Roche Diagnostics` Genome Sequencer 20 System Powers MWG Biotech AG/ Eurofins | Medigenomix Sequencing Service
22.11.2006  Bio-Gate AG is awarded the Bernd-Artin Wessels-Preis
21.11.2006  Pathbreaking study course cooperation with Roche Diagnostics
17.11.2006  MediGene AG Upgrades Patent Portfolio in the Field of Cancer-Killing Viruses (Oncolytic HSV)
15.11.2006  Cluster-News Ausgabe November
15.11.2006  IDEA AG receives approvable letter from Swissmedic for IDEA-033, a novel carrierbased, targeted analgesic, for the treatment of signs and symptoms of osteoarthritis
13.11.2006  MorphoSys and Boehringer Ingelheim Expand Collaboration with new Cancer-Related Antibody Program
10.11.2006  WILEX shares successfully placed at EUR 13.80
07.11.2006  4SC AG and the Institute of Molecular Virology at the University of Münster were successful in developing an active agent for fighting the H5N1 virus
07.11.2006  Ein Pfad - zwei Effekte: Immunsystem nützt DNA-Reparaturmechanismus zur Steigerung der Abwehr
07.11.2006  University Würzburg supports founders of companies
06.11.2006  KINAXO announces agreement with UCB
05.11.2006  Company Mission to Montréal (Quebec) Canada
05.11.2006  Scientific partnering and conference mission to Montréal
31.10.2006  MediGene AG Obtains Approval of Polyphenon® E Ointment in the USA
30.10.2006  Discovery of small regulators of stem cell self-renewal at GSF
30.10.2006  EPIDAUROS partner of Boehringer Ingelheim in multicenter trial
27.10.2006  MorphoSys Reports Nine Months 2006 Results
26.10.2006  Affectis Pharmaceuticals AG attracts € 12 Million Venture Capital Investment, Strengthens Team
26.10.2006  Pieris confirms in vivo activity of potent VEGF-specific Anticalin®
25.10.2006  Micromet Presents New Anti-IL-2 Antibody with Unique Mode of Action
25.10.2006  Retrospective: Cooperation Forum 'Renewable Resources - Potential for Energy and Chemistry'
24.10.2006  WILEX announces details of IPO
23.10.2006  From Garching Innovation to Max Planck Innovation
20.10.2006  WILEX’s antibody based diagnostic imaging agent demonstrates 100 % positive predictive accuracy in feasibility study on kidney cancer
19.10.2006  Außenwirtschaft / Messebeteiligungsprogramm (Bayern)
19.10.2006  Canada's New Government Funds New Bio-Fibre Research
19.10.2006  Impulse für Innovationen
18.10.2006  GSF scientist successful at the Go-Bio competition of the Federal Ministry of Education and Reseach (BMBF)
16.10.2006  Osmetech licenses pharmacogenetic marker for P450-CYP2D6 from Epidauros
16.10.2006  WILEX successfully completes Phase II study with RENCAREX®* in combination with Interferon
15.10.2006  Sloning bringt Genvarianten-Bibliotheken (SlonoMax™) mit bislang unübertroffener Qualität auf den Markt
13.10.2006  BMBF increases the funding for biotechnolgy companies to 200 million Euro
13.10.2006  Excellence Initiative: Future concept can start at the Technische Universität München (TUM)
13.10.2006  Excellence Initiative: Munich University best in Germany, aiming for world elite
11.10.2006  European Regulatory Authority Recommends Orphan Drug Designation for MediGene's Drug Candidate EndoTAG-1
11.10.2006  Intermediary result of the conversion of convertible bonds
11.10.2006  WILEX Plans IPO
10.10.2006  4SC achieves next milestone in drug discovery collaboration with Sanwa Kagaku Kenkyusho
10.10.2006  LipoFIT successful in financing round
05.10.2006  Novel Bio-plastics from sugar beets & Co
02.10.2006  Micromet and Serono report from two Phase II Trials: Activity of Adecatumumab (MT201) in Breast and Prostate Cancer indicated
02.10.2006  Nobel Prize in Physiology or Medicine for 2006: "RNA interference – gene silencing by double-stranded RNA"
02.10.2006  Startschuss für den Businessplan-Wettbewerb Nordbayern 2007
29.09.2006  MediGene AG Successfully Closes Acquisition of UK-based Avidex Ltd.
29.09.2006  MediGene Obtains US Patent on EndoTAG-1
28.09.2006  German Skin Cancer Prize awarded to reseacher couple at the Rudolf-Virchow-Center
27.09.2006  Crystallographic analysis of Anticalin® targeting CTLA-4 confirms the excellent suitability of Pieris’ lipocalin scaffold to develop superior biotherapeutics
25.09.2006  MorphoSys and U.S. Army Enter into Biodefense Cooperation - MorphoSys's AbD Serotec Awarded Sole Supplier Contract to USAMRIID
24.09.2006  GPC Biotech and Pharmion Announce Positive Results from the Satraplatin Pivotal Phase 3 Trial and Achievement of the Progression-Free Survival Endpoint
15.09.2006  MediGene: Dose-Finding Trial of Oncolytic Virus NV1020 for the Treatment of Liver Metastases Shows Efficacy Trends
14.09.2006  Genomatix wins BioChance grant for $ 1.6 Mio research project into RNAi mediated regulatory networks
12.09.2006  NascaCell Technologies AG announces R&D collaboration with AstraZeneca
08.09.2006  Mit Gensonden Gammelfleisch schneller entdecken - vermicon AG mit neuartiger Nachweismethode
07.09.2006  Internationale Initiative zur Funktionsaufklärung aller Gene gestartet
01.09.2006  Bio-M Biotech Cluster Development GmbH
31.08.2006  Micromet Secures $ 25 Million Committed Equity Financing Facility
30.08.2006  MediGene Signs Agreement to Acquire UK-Based Avidex Ltd. in a EUR 50 Million Share-for-Share Transaction
25.08.2006  Genomforscher tauschen Wissen aus
22.08.2006  Web application enhances security of synthetic biology
21.08.2006  MedImmune Files Investigational New Drug Application for MT103
20.08.2006  Celgene Deutschland zieht in ihre neuen Geschäftsräume in München-Riem
17.08.2006  MorphoSys Obtains PER.C6® Human Cell Line for Production of Antibody Material in MOR103 Program
16.08.2006  EU-Zulassung für Krebsmedikament krönt Grundlagenforschung der Max-Planck-Gesellschaft
08.08.2006  Neue Analyseverfahren am Fraunhofer IVV für Perfluorierte Tenside (PFT) und dioxinähnliche PCB
07.08.2006  WILEX completes Phase I program with anti-cancer drug WX-671 in healthy volunteers and holds clinical Phase Ib study in cancer patients now
02.08.2006  GPC Biotech Initiates Phase 2 Randomized Trial Evaluating Satraplatin plus Tarceva® in Patients with Advanced Non-Small Cell Lung Cancer
02.08.2006  IDEA AG announces successful completion of its pivotal Ph III study in Europe
01.08.2006  Ausschreibung des Nachwuchswissenschaftler-Preises für Naturstoff-Forschung 2007
31.07.2006  WILEX completes two Phase Ib studies with anti-cancer drug WX-UK1 in cancer patients
28.07.2006  Neue Funktion durch Partnerwechsel
27.07.2006  KINAXO enters into agreement with Schering AG on kinase inhibitor profiling
27.07.2006  KINAXO receives seed funding and licensing rights for KinaTorTM technology
27.07.2006  US Patent Granted for 4SC’s Clinical Project
26.07.2006  PreSens develops new sensor system
26.07.2006  Studie über Biotechnologie in Polen veröffentlicht
24.07.2006  Affectis Pharmaceuticals AG Identifies Novel Target for the Treatment of Unipolar Disorder
24.07.2006  Micromet Announces Definitive Agreement for $ 8.0 Million Private Placement
21.07.2006  MedImmune and Micromet Report on Novel Anti-cancer BiTE(R)
19.07.2006  Bayern – Fit for Partnership: Moderne Wassertechnologie aus Bayern für Rumänien
18.07.2006  Nutritionists examine probiotics
17.07.2006  Biomedical cooperation project Cell3D completed successfully
17.07.2006  Entelechon receives BioChance Plus funding for a new method of protein quantification
17.07.2006  Neuer Schalter des Immunsystems entdeckt: Identisches Enzym fördert und dämpft die Immunaktivierung
14.07.2006  Edition 3, 2006 - News 'Life Science Bavaria'
13.07.2006  Neuer Sprecher für das Nationale Genomforschungsnetz
13.07.2006  S.u.K. Vienna, TopLab and IMGM to study blood, gene and protein expression in Diabetes Type II patients
12.07.2006  GPC Biotech Submits Non-Clinical Section of Rolling NDA for Lead Oncology Drug Candidate Satraplatin
12.07.2006  Prediction and prevention.…
12.07.2006  Renewable Raw Materials – New Opportunities for the Energy and Chemical Industries
12.07.2006  TRANSBIO EU Project - Matching Transoceanic Biotech Opportunities
12.07.2006  vermicon AG strengthened by successful financing
10.07.2006  BIO-DISC Project
10.07.2006  Genedata Collaborates with HepatoSys Systems Biology Competence Network
06.07.2006  ibidi publishes new data on homogeneous cell growth inside µ-channels
06.07.2006  MediGene and German Cancer Research Center to Develop Antibody against Ovarian Cancer
06.07.2006  Pieris reaches key milestones under the collaboration agreement with Syngenta
05.07.2006  Origenis extends Research Alliance with Alcon to develop novel ophthalmic compounds
04.07.2006  Statement re Insolvency
03.07.2006  Spider silk - The material of the future
01.07.2006  Adult stem cells - ForNeuroCell providing research for Parkinsons and Paralysis patients
30.06.2006  FDA Extends PDUFA Date for Polyphenon® E Ointment to October 31, 2006
29.06.2006  GENEART AG named 'BAYERNS BEST 50'
29.06.2006  Immunologische Ansätze der Krebstherapie - Sonderforschungsbereich /Transregio in Berlin und München eingerichtet
28.06.2006  4SC announces further research collaboration with Solvay
Print
zum Seitenanfang